OKI Electric Cable, a tech company specializing in electric cables, launched Stretchable Flexible Printed Circuits, better known as Stretchable FPC. The product is part of the new Oki Electric Cable product lineup to be introduced in June 2019.

Related Body- Hugging Elastic Printed Circuit Board Allows Measurement of Heart and Lung Function Directly on the Skin

The astonishing technological advances and the growing sophistication of electronic devices in recent years have generated demand for new characteristics in the flexible printed circuits (FPCs) used as wiring materials.

Wiring materials for smart clothes and smart patches should have the ability to mount functional parts, in addition to light weight, thin profile, and the flexibility needed to ensure comfort when worn. These materials must also provide elasticity needed to accommodate the various movements of the human body. While existing FPCs offer light weight, thin profile, flexibility, and mountability, they lack elasticity, reports OKI.

OKI’s new Stretchable FPC offers elasticity by replacing the polyimide widely used in existing FPCs with an elastic substrate. This elastic substrate can be stretched repeatedly, like rubber, and is heat-resistant, allowing components to be solder-mounted. Its circuit conductor incorporates the same copper wiring as existing FPCs but the wiring method is specially designed to allow it to work with the stretchable substrate. The use of copper wiring minimizes variations in conductor resistance due to FPC expansion or contraction, allowing use of the FPC as a sensor. Potential applications for the Stretchable FPC include use as a wearable sensor to help diagnose disease in the chest; the Stretchable FPC is wrapped around the chest to measure signal fluctuations in the copper wiring.

Related CPI, ItoM Medical and Blumorpho Working on Next Gen Smart Vest for Children with Asthma

The Stretchable FPC can be used as elastic wiring material in wearable devices and will contribute to the ever-growing sophistication of electronic devices. Oki Electric Cable will continue to proactively develop new products to meet constantly diversifying customer needs.

WT | Wearable Technologies Conference in San Francisco on July 9-10

The most innovative wearables event will be back on July 9-10 in beautiful San Francisco at SEMICON West to celebrate the 34th edition of the WT | Wearable Technologies Conference Series. Topics include data analytics in professional sports, prevention, treatment and rehabilitation with wearables, the future of digital health, medication and adherence, smart patches, workflow optimization and workforce safety and much more – featuring international leaders and experts of the wearables industry´s biggest names including Abbott, Autodesk, Datwyler, Kopin, Maxim Integrated, Multek, NFLPA, Omron, SharkDreams, Qualcomm, and many more. Register now to be part of #WTUS19

Macronix, a leading integrated device manufacturer in the Non-Volatile Memory (NVM) market, provides a full range of NOR Flash, NAND Flash, and ROM products. With its world-class R&D and manufacturing capability, Macronix continues to deliver high-quality, innovative and performance-driven products to its customers in the consumer, communication, computing, automotive, networking and other market segments.

Read more MediaTek Accelerates 5G Rollout with Helio M70 5G Modem for Sub-6GHz Spectrum

Macronix ArmorFlash combines mature security technologies such as unique ID, authentication and encryption features to deliver superior data protection in high-density memory devices. OctaFlash provides fast data-transfer-rates operation frequency and high throughput that meet the “instant-on” performance demands for real-time system responsiveness in automotive, industrial and consumer applications. Macronix’s MX25R flash family features a broad array products with a wide voltage range suitable for IoT and other energy-conscious applications such as wearable, wireless and mobile devices, said the company in a press release.

Macronix was established in 1989 in the Science Park, Hsinchu, Taiwan.

In recent years, the company dedicated 20% of its annual revenue to Research and Develop. Their technical papers have been published and presented in major international conferences, such as IEDM and ISSCC. Macronix has been granted more than 7,400 patents and continues its investment in advanced technology development. The Taiwan-based company provide is jointly developing technology for Phase Change memories along with its high technology alliance partners in the world. The company also announced the world’s first Flash prospective technology, BE-SONOS™.

WT | Wearable Technologies Conference in San Francisco on July 9-10

The most innovative wearables event will be back on July 9-10 in beautiful San Francisco at SEMICON West to celebrate the 34th edition of the WT | Wearable Technologies Conference Series. Topics include data analytics in professional sports, prevention, treatment and rehabilitation with wearables, the future of digital health, medication and adherence, smart patches, workflow optimization and workforce safety and much more – featuring international leaders and experts of the wearables industry´s biggest names including Abbott, Autodesk, Datwyler, Kopin, Maxim Integrated, Multek, NFLPA, Omron, SharkDreams, Qualcomm, and many more. Register now to be part of #WTUS19

Disc Pump™ micropump manufacturer TTP Ventus has launched its latest product line, the LT Series, to be used in the medical, life science, environmental and industrial sectors. The LT Series micropumps offer 5,000 hours’ continuous operation across wide temperature range.

Read more Realize Your Vision of the Next Medical Applications

Micropumps are devices that can control and manipulate small fluid volumes. Such pumps are of special interest in microfluidic research, and have become available for industrial product integration in recent years.

TTP Ventus’ Disc Pump platform is a silent micropump platform that delivers exceptional pressure and flow, millisecond-response time, precision controllability and pulsation-free flow. These features enable product designers to drive innovation, for example through the creation of discrete, wearable medical devices or through the miniaturization of measurement equipment. The LT Series is a new addition to the line-up, providing in excess of 5,000 hours’ continuous operation across a wide temperature range of -25 to +40°C, reports Business Wire.

“The LT series marks a significant step forward in the lifetime capacity of our technology. The first two models in the series extend the envelope over previous designs, allowing us to support 6 months’ continuous operation. It is remarkable to consider that over this time, cycling 20,000 times per second, the pump will clock up more than 20 cycles for every year the universe has existed,” said Tom Harrison, Business Development Manager, TTP Ventus.

Read more Itamar Medical’s WatchPAT 300 is a Simple and Reliable Home Sleep Apnea Detection System

“We are committed to pushing the capability of our designs and are developing models offering further improvements to performance and life. We have a series of products planned for release over the course of the next year, ultimately targeting a pump rated to 10,000 hours in 2020.”

WT | Wearable Technologies Conference in San Francisco on July 9-10

The most innovative wearables event will be back on July 9-10 in beautiful San Francisco at SEMICON West to celebrate the 34th edition of the WT | Wearable Technologies Conference Series. Topics include data analytics in professional sports, prevention, treatment and rehabilitation with wearables, the future of digital health, medication and adherence, smart patches, workflow optimization and workforce safety and much more – featuring international leaders and experts of the wearables industry´s biggest names including Abbott, Autodesk, Datwyler, Kopin, Maxim Integrated, Multek, NFLPA, Omron, SharkDreams, Qualcomm, and many more. Register now to be part of #WTUS19

Senseonics, a company that develops implantable continuous glucose monitoring (CGM) system for people with diabetes, received FDA approval for the non-adjunctive indication (dosing claim) for its Eversense CGM.

Related Nemaura’s SugarBeat Non-Invasive CGM Gets CE Approval

The CGM System consists of a fluorescence-based sensor, a smart transmitter worn over the sensor to facilitate data communication, and a mobile app for displaying glucose values, trends and vibratory alerts for high and low glucose and can be removed, recharged and re-attached to the skin without discarding the sensor. People with diabetes can use this system instead of the traditional finger prick tests to make diabetes-related decisions.

“We are pleased with the results of the European Eversense PMCF registry which demonstrate the safety of the Eversense CGM System in a large group of patients,” said Katherine Tweden, PhD, Vice President of Clinical Sciences at Senseonics. “This post-market study was an opportunity to evaluate the real-world experience of Eversense and Eversense XL CGM as patients wore their first, second, third and fourth sensors. The results, with 3,667 patient-years of wear, demonstrated a strong safety profile over repeat sensor cycles for the first long-term implantable sensor.”

Related Medtronic Buys AI-powered Nutrition Platform Nutrino to Boost Diabetes Offering

Past clinical studies evaluated the safety of the system using a study design of one insertion and removal cycle. Safety data from 3,066 Eversense users from 15 European countries was collected and reported. Repeat insertions of the Eversense CGM confirmed the safety profile of prior studies and showed it to be safe for long-term continuous use.

WT | Wearable Technologies Conference in San Francisco on July 9-10

The most innovative wearables event will be back on July 9-10 in beautiful San Francisco at SEMICON West to celebrate the 34th edition of the WT | Wearable Technologies Conference Series. Topics include data analytics in professional sports, prevention, treatment and rehabilitation with wearables, the future of digital health, medication and adherence, smart patches, workflow optimization and workforce safety and much more – featuring international leaders and experts of the wearables industry´s biggest names including Abbott, Autodesk, Datwyler, Kopin, Maxim Integrated, Multek, NFLPA, Omron, SharkDreams, Qualcomm, and many more. Register now to be part of #WTUS19

Senior care service provider Cerna Home Care launched “Onhand Assistance” – a smartwatch especially designed for seniors. The stylish wearable device provides fall detection, fall notification, vitals monitoring, cellular communication, and medication reminders – in addition to life saving calls and care. Every second an older adult fall, making falls the number one cause of injuries and deaths from injury among older Americans. In 2014 alone, 29 million falls among elderly Americans resulted in seven million injuries and costing an estimated $31 billion in annual Medicare costs, according to a new report published by the Centers for Disease Control and Prevention in this week’s Morbidity and Mortality Weekly Report (MMWR).

Related Wearable Accelerometers Can Predict Seniors’ Risk of Falling, Says Study

Onhand Assistance helps lessen the need for expensive personal caregivers and avoids time consuming ambulance trips to the hospital due to false alarms. Family members monitor their loved one through the Onhand Assistance smartphone app. Seniors, their friends and their families benefit by being better connected inexpensively and effectively, says a press release.

“There are many devices on the market for seniors that contact a call center with the push of a button. However, there are none combining cell phone features, auto fall detection, automatic calling, medication reminders, vitals monitoring and GPS location monitoring, explains Cerna Home Care’s Founder and CEO, Nick Payzant. “Onhand Assistance sends family members alerts via the smartphone app. It also calls and dispatches a senior care professional (not a call center employee that may have no experience with senior care) who can administer a full range of care services at home or can help determine if emergency personnel is needed.”

Related These Wearables Are Helping Seniors Stay Safe and Healthy

Features of the Onhand Assistance include:

• Fall detection and automatic SOS alert
• SOS distress button
• Two-way calling
• GPS tracking and history displacement
• Heart rate monitor
• Medication reminders
• Safe zone set-up
• Push button family calling

“The Onhand Assistance smartwatch solution fills the gaps in today’s wearable medical alert devices. In caring for the elderly, we listened to family members, care recipients, hospitals and rehab centers asking for a more robust way to be connected and safe,” said Payzant.

WT | Wearable Technologies Conference in San Francisco on July 9-10

The most innovative wearables event will be back on July 9-10 in beautiful San Francisco at SEMICON West to celebrate the 34th edition of the WT | Wearable Technologies Conference Series. Topics include data analytics in professional sports, prevention, treatment and rehabilitation with wearables, the future of digital health, medication and adherence, smart patches, workflow optimization and workforce safety and much more – featuring international leaders and experts of the wearables industry´s biggest names including Abbott, Autodesk, Datwyler, Kopin, Maxim Integrated, Multek, NFLPA, Omron, SharkDreams, Qualcomm, and many more. Register now to be part of #WTUS19

Sleep apnea is a potentially serious sleep disorder in which breathing repeatedly stops and starts. A study showed that people with severe sleep apnea may be up to three times more likely to die prematurely, and that risk increases if the sleep disorder is left untreated. If you snore loudly and feel tired even after a full night’s sleep, you might have sleep apnea.

On March, Wearable Technologies reported on a device called WatchPAT 300 Home Sleep Apnea Detection System. WatchPat 300 received FDA clearance in August 2018, and now, the company’s new device WatchPat One received clearance from the U.S. Food and Drug Administration (FDA).

WatchPAT™ One is developed by an Israel-based company Itamar Medical Ltd. Itamar develops, manufactures and markets non-invasive diagnostic medical devices for sleep apnea with a focus on the cardiology market, the company said in a news release.

WatchPAT One is the first and only fully disposable Home Sleep Apnea Test (HSAT). The system incorporates the technology and comfort advances of WatchPAT 300, which received 510(k) clearance in August 2018 and was launched in March 2019.

“WatchPAT One is ideally suited for clinics and practices that recognize the value of HSAT but have limited resources, infrastructure or capital to invest in acquiring or managing our reusable WatchPAT products,” said Gilad Glick, President and Chief Executive Officer of Itamar Medical. “WatchPAT One offers patients and physicians the same simplicity, accuracy and reliability as WatchPAT 300 without the need for return shipping, downloading, cleaning or preparation for the next study. We expect the availability of a disposable WatchPAT system will improve patient access by increasing the number physicians able to offer our cutting-edge technology to their patients. Additionally, as a disposable HSAT, WatchPAT One may have particular utility in the inpatient setting, where transmission of infection through reusable medical devices is a significant concern.”

Related This Wearable Sleep Tracker Can Help Detect Your Sleep Apnea

The device can be paired with a smartphone using Itamar’s proprietary app. Sleep study data are collected during the test and automatically sent to CloudPAT™, Itamar’s secure server.

WT | Wearable Technologies Conference in San Francisco on July 9-10

The most innovative wearables event will be back on July 9-10 in beautiful San Francisco at SEMICON West to celebrate the 34th edition of the WT | Wearable Technologies Conference Series. Topics include data analytics in professional sports, prevention, treatment and rehabilitation with wearables, the future of digital health, medication and adherence, smart patches, workflow optimization and workforce safety and much more – featuring international leaders and experts of the wearables industry´s biggest names including Abbott, Autodesk, Datwyler, Kopin, Maxim Integrated, Multek, NFLPA, Omron, SharkDreams, Qualcomm, and many more. Register now to be part of #WTUS19

Over 30 million speech impaired people around the globe relies on sign language as a means of communication. But sign language isn’t understood by most of the people on the planet, which creates a communication barrier for the people with speech impairment.

Read more This AI-Powered Smart Glove Can Identify Objects by Touch

Roy Allela, a 25-year-old Kenyan man has invented smart gloves that can convert hand gestures of sign language into audio speech. This innovation could change the lives of hearing-impaired people across the world.

Dubbed Sign-IO, the gloves have sensors stitched to each finger. The sensors interpret the word being signed from the bend of the finger.

Allela said challenges faced by his deaf niece inspired him to create the gloves. He also said that the speed at which the signs are vocalized is one of the most important aspects of the smart gloves:

“My 6-year-old niece wears the gloves, pairs them to her phone or mine, then starts signing and I’m able to understand what she’s saying,” says Allela.

“People speak at different speeds and it’s the same with people who sign – some are really fast, others are slow, so we integrated that into the mobile application so that it’s comfortable for anyone to use it.”

Read more ProGlove Unveils Mark 2, State-of-the-Art Handsfree Barcode Scanner

The Sign-IO delivers give translations in real-time and the gloves can be set to customized interpretation speeds, explains Allela. The device can also be altered to manipulate the pitch, speed and tone of the voice, reports CapeTalk.

Allela is among 16 young Africans who have been shortlisted by The Royal Academy of Engineering Africa Prize for inventors from six countries. He says the recognition is a wonderful validation of his work and a great opportunity to put African inventors on the map.

WT | Wearable Technologies Conference in San Francisco on July 9-10

The most innovative wearables event will be back on July 9-10 in beautiful San Francisco at SEMICON West to celebrate the 34th edition of the WT | Wearable Technologies Conference Series. Topics include data analytics in professional sports, prevention, treatment and rehabilitation with wearables, the future of digital health, medication and adherence, smart patches, workflow optimization and workforce safety and much more – featuring international leaders and experts of the wearables industry´s biggest names including Abbott, Autodesk, Datwyler, Kopin, Maxim Integrated, Multek, NFLPA, Omron, SharkDreams, Qualcomm, and many more. Register now to be part of #WTUS19

Lung cancer kills 160,000 people in the U.S. every year and the global death toll from the disease is around 2 million. Lung cancer can be lurking in plain sight, only to be detected too late to be properly treated. Like all cancers, the best chance for a successful treatment of lung cancer depends on early detection by screening people at high risk for the disease, such as smokers. However, these screenings aren’t perfect, and the subtle difference between a harmful tumor (malignant) and a harmless tumor (benign) can be difficult to distinguish from a CT scan.

Related AI Tool Accurately Detects Cancer Type and Genetic Changes in Patient’s Tumor

A collaboration between Google and medical partners including Northwestern University revealed a new AI-based tool that can create a better model of a patient’s lung from the CT scan images. This 3-D image helps AI to better predict malignancy of tumors by learning from previous scans. The system was able to confirm evidence of cancer more quickly and had fewer false positive and false negatives than its human counterparts.

“This area of research is incredibly important, as lung cancer has the highest rate of mortality among all cancers, and there are many challenges in the way of broad adoption of lung cancer screening,” Shravya Shetty, the technical lead at Google, said in a University release. “Our work examines ways AI can be used to improve the accuracy and optimize the screening process, in ways that could help with the implementation of screening programs.”

While lung cancer cells can be destroyed if detected soon enough, only a small number of the eligible U.S. population is screened for lung cancer, according to Google. A more advanced system may be able to detect lung cancer quickly and influence more people to screen for the disease.

Related Graphene Biosensor Could Provide Early Diagnosis of Lung Cancer

“Radiologists generally examine hundreds of two-dimensional images or ‘slices’ in a single CT scan but this new machine learning system views the lungs in a huge, single three-dimensional image,” study co-author and anesthesiology and engineering Prof. Mozziyar Etemadi said in the release. “AI in 3D can be much more sensitive in its ability to detect early lung cancer than the human eye looking at 2-D images. This is technically ‘4D’ because it is not only looking at one CT scan, but two (the current and prior scan) over time.”

WT | Wearable Technologies Conference in San Francisco on July 9-10

The most innovative wearables event will be back on July 9-10 in beautiful San Francisco at SEMICON West to celebrate the 34th edition of the WT | Wearable Technologies Conference Series. Topics include data analytics in professional sports, prevention, treatment and rehabilitation with wearables, the future of digital health, medication and adherence, smart patches, workflow optimization and workforce safety and much more – featuring international leaders and experts of the wearables industry´s biggest names including Abbott, Autodesk, Datwyler, Kopin, Maxim Integrated, Multek, NFLPA, Omron, SharkDreams, Qualcomm, and many more. Register now to be part of #WTUS19

Poznan, Poland-based AI startup StethoMe won European CE marks for its digital stethoscope and accompanying software that detect respiratory issues in children.

Read more Wearable Digital Thermometer Detects Fever Quicker than Current SOC method

The wireless stethoscope combines AI algorithm to examine children’s lung and heart recordings. StethoMe is intended to be used by parents to check on their kids when there are signs of sickness. Instead of immediately bringing the child in for an exam, a parent can perform a basic auscultation and send the recording for analysis by the company’s AI-powered algorithms to look for signs of distress, reports MedGadget.

The consistency between doctors in the recognition of auscultation sounds in primary care is very low – ranging from 20% to 80%*. Examinations with a traditional stethoscope depend on the experience and parameters of the physician’s auditory system. Medically tested, StethoMe has shown to increase accuracy by up to 13%. Results are shared directly with a doctor who then advises as to whether that child needs to visit a doctor or emergency room, or can remain at home under close supervision, StethoMe said in a news release.

“There are two main issues facing primary care. Firstly, the high rate of misdiagnosis that occurs (​cases of delayed, missed, and incorrect diagnosis are common – in the range of 10 per cent to20 per cent​ and, secondly, the very high number of unnecessary visits ​(​up to 70 per cent in the US. We are beginning to see AI affect the world we live in substantially and the healthcare sector is no different. This is why we created StethoMe – to help address these challenges,” said Wojciech Radomski, CEO, StethoMe.

Read more New Technology From 3M Monitors Breathing And Helps You Improve Respiratory Health

“What is unique about StethoMe is that we’re not a team of scientists or inventors who decided to create a product like this. Most of us are parents of young children who have faced challenging times where we’ve needed to visit doctors regularly. After experiencing these problems, we decided to do something about it, and offer parents a better way to ensure their children are healthy,” added Honorata Hafke-Dys Phd., Chief Medical Officer and co-founder, StethoMe.

WT | Wearable Technologies Conference in San Francisco on July 9-10

The most innovative wearables event will be back on July 9-10 in beautiful San Francisco at SEMICON West to celebrate the 34th edition of the WT | Wearable Technologies Conference Series. Topics include data analytics in professional sports, prevention, treatment and rehabilitation with wearables, the future of digital health, medication and adherence, smart patches, workflow optimization and workforce safety and much more – featuring international leaders and experts of the wearables industry´s biggest names including Abbott, Autodesk, Datwyler, Kopin, Maxim Integrated, Multek, NFLPA, Omron, SharkDreams, Qualcomm, and many more. Register now to be part of #WTUS19

CyMedica, a digital health and muscle strengthening therapy innovator and a former exhibitor of the WT | Wearable Technologies Show at MEDICA, launched a clinical trial to evaluate the effectiveness of their e-vive™ muscle strengthening device and patient engagement system in knee osteoarthritis patients.

CyMedica will conduct a randomized, prospective clinical trial on 120 osteoarthritis patients in collaboration with Northwell Health, New York’s largest health system. The data collected from e-vive will be combined with data collected by commercially available smartwatches to determine the effect of this novel technology on improving symptoms of osteoarthritis (OA). The study is being led by researchers Matthew Stewart Hepinstall, MD (Primary Investigator) and Michael A. Mont, MD., said a press release.

Related QUANTIC NANOTECH Will Present the First Real Wearable for Osteoarthritis

“The e-vive clinical trial for knee osteoarthritis marks a major advancement for CyMedica in the treatment landscape for managing osteoarthritis knee pain,” said Rob Morocco, President and Chief Executive Officer. “It comes at a time when an overwhelming number of knee arthritis patients are in urgent need of non-narcotic, non-addictive and home-based wearable therapies to help the millions of Americans who suffer from this painful chronic condition.”

Osteoarthritis is the most common form of arthritis, and the knee is one of the most commonly affected joints. Knee arthritis can make it hard to do many everyday activities, such as walking or climbing stairs. Muscle weakness is considered one of the most common underlying clinical conditions associated with knee osteoarthritis and the rehabilitation challenges facing patients recovering from knee procedures.

Related MANOVIVO: Wearable Smart Glove Offering Custom Support for People with Rheumatoid Arthritis

Dr. Michael A. Mont, Vice President of Strategic Operations in Orthopedics at Northwell Health, said:

“The success of the e-vive™ quadriceps muscle-strengthening in post-surgical knee rehabilitation has been well documented. Through this clinical trial, CyMedica and Northwell Health have a unique opportunity to positively measure the effectiveness of e-vive muscle strengthening using a novel, app-based patient-engagement system and smartwatch technology, which patients are already wearing. In turn, patients are able to better manage their symptoms earlier in their knee osteoarthritis journey.”

WT | Wearable Technologies Conference in San Francisco on July 9-10

The most innovative wearables event will be back on July 9-10 in beautiful San Francisco at SEMICON West to celebrate the 34th edition of the WT | Wearable Technologies Conference Series. Topics include data analytics in professional sports, prevention, treatment and rehabilitation with wearables, the future of digital health, medication and adherence, smart patches, workflow optimization and workforce safety and much more – featuring international leaders and experts of the wearables industry´s biggest names including Abbott, Autodesk, Datwyler, Kopin, Maxim Integrated, Multek, NFLPA, Omron, SharkDreams, Qualcomm, and many more. Register now to be part of #WTUS19

A lack of sleep not only makes you cranky but over time, skimping sleep can impact your health negatively. Studies have shown that for a good health, a good night’s sleep is just as important as eating healthy and exercising. Tel Aviv, Israel-based innovative corporate sleep solution provider dayzz has integrated with Garmin wearables to provide personalized sleep training plans based on users’ own sleep data, helping improve overall quantity and quality of sleep.

Related The 5 Best Wearables for Getting a Good Night’s Sleep

With this integration Garmin users will receive actionable recommendations to improve their sleep. To stay in physical and mental condition, runners also need quality sleep. Runners’ sleep data will automatically sync with the dayzz app, updating their personal in-app sleep tracker with information such as what time they went to bed, how long it took them to fall asleep, how many times they woke up throughout the night and other factors that affect their sleep. The sleep tracker will instinctively update every day based on the previous night, which will save users time and mitigate possible inaccuracies due to human error, says a press release.

“We are excited to be working with Garmin, and believe that this integration is an important step forward in providing value to the market, targeting runners and athletes,” said Amir Inditzky, CEO of dayzz. “Sleep is a core pillar of health, affecting almost every tissue in our systems. While we sleep, our body renews and resets in order to function properly the next day. This is especially important for athletes to repair and restore their muscles. Garmin users will receive personalized guidance based on their sleep data in order to improve their performance through healthy sleep routines.”

Related Itamar Medical’s WatchPAT 300 is a Simple and Reliable Home Sleep Apnea Detection System

WT | Wearable Technologies Conference in San Francisco on July 9-10

The most innovative wearables event will be back on July 9-10 in beautiful San Francisco at SEMICON West to celebrate the 34th edition of the WT | Wearable Technologies Conference Series. Topics include data analytics in professional sports, prevention, treatment and rehabilitation with wearables, the future of digital health, medication and adherence, smart patches, workflow optimization and workforce safety and much more – featuring international leaders and experts of the wearables industry´s biggest names including Abbott, Autodesk, Datwyler, Kopin, Maxim Integrated, Multek, NFLPA, Omron, SharkDreams, Qualcomm, and many more. Register now to be part of #WTUS19

INNOVO is an FDA-cleared non-invasive wearable to treat Stress Urinary Incontinence (SUI) in women. Developed by Atlanta Therapeutics, INNOVO sends targeted and pain-free muscle stimulations through a pair of shorts, via neuromuscular electrical stimulation (NMES), to safely and effectively strengthen the muscles in the pelvic floor.

Related Femtech Hardware Elvie Partners with NHS to Tackle Stress Urinary Incontinence

“’OMG. I just free’d myself!’ Today, 20 million women in America will rewrite that whispered, uncomfortable admission of bladder weakness1 into a declarative, celebratory shout thanks to INNOVO®, said the company in a press release.

The INNOVO thigh-length, elasticized therapeutic shorts are outfitted with eight electrodes sewn in a crisscross formation across the pelvic region. When activated via its attached hand-held controller, INNOVO delivers a series of pelvic stimulations equivalent to Kegel exercises for strengthening the pelvic floor.

“INNOVO can help women declare freedom from incontinence and independence from pads,” said Dr. Nita Landry, board-certified OB/GYN and co-host of the Emmy® Award-winning television show “The Doctors.”  “These innovative, therapeutic shorts with targeted muscle stimulations empower women to treat the source for a long-term solution, rather than rely on a short-term pad to manage the problem.”

According to the Urology Care Foundation, one in three (20 million) women suffer from SUI at some point in their life. Of those women, 23 percent report it negatively impacts their sex lives and 31 percent dress differently because of their symptoms. Of the 33 percent of women who experience SUI after childbirth, 65 percent are still affected over the next dozen years.

Related DFree Wearable Device for Urinary Incontinence Launches in US

Women can use the device in the privacy and comfort of their home while either standing, reclining or lying down. The recommended treatment is 30-minutes a day, five days a week, for three months. After the three-month period, it is recommended that INNOVO be used once a week for 30-minutes. In each 30-minute session, INNOVO delivers 180 perfect pelvic floor stimulations (or Kegels).

WT | Wearable Technologies Conference in San Francisco on July 9-10

The most innovative wearables event will be back on July 9-10 in beautiful San Francisco at SEMICON West to celebrate the 34th edition of the WT | Wearable Technologies Conference Series. Topics include data analytics in professional sports, prevention, treatment and rehabilitation with wearables, the future of digital health, medication and adherence, smart patches, workflow optimization and workforce safety and much more – featuring international leaders and experts of the wearables industry´s biggest names including Abbott, Autodesk, Datwyler, Kopin, Maxim Integrated, Multek, NFLPA, Omron, SharkDreams, Qualcomm, and many more. Register now to be part of #WTUS19

Stroke is a leading cause of disability, which affects approximately 17 million people worldwide each year, and as many as 80% of people who have had a stroke will suffer from gait impairments.

Related Scientists Develop Groundbreaking Multi-Joint, Personalized Wearable Soft Exosuit

ReWalk Robotics, a leading manufacturer of robotic medical devices for people with lower limb disabilities, received FDA clearance for its ReStore™ soft exosuit system for sale to rehabilitation centers across the United States. ReStore is the only soft exosuit with FDA clearance, and is intended for use in the treatment of stroke survivors with mobility challenges, the company said in a press release.

“The exo-suit achieves our commercial goal to offer a functional and affordable system that can be utilized in the ‘Main Street’ clinics in every community,” said ReWalk CEO Larry Jasinski. “With a launch price of $28,900 as well as leasing options, ReStore offers cutting edge innovation with features that redefine therapy at a price that is accessible for a broader range of clinics than existing robotic technologies. The current gait training reimbursement codes enable immediate penetration and sales growth as part of our pathway to become a break even and profitable company.”

The technology was originally developed at Harvard University’s Wyss Institute for Biologically Inspired Engineering. The system, comprised of a soft garment-like design, connects to a lightweight waist pack and mechanical cables that help lift the patient’s affected leg in synchronized timing with their natural walking pattern. ReStore provides targeted assistance to the patient during forward propulsion (plantarflexion) and ground clearance (dorsiflexion), two key phases of the gait cycle. The device also provides the physical therapists with extensive data during gait training with ReStore to inform strategies to optimize a patient’s treatment and progress using real-time analytics.

Related Fire Proof Exoskeleton Promises to Reduce Work-Related Injury

“We are very encouraged by our initial experience and positive impact of ReStore in gait training for persons with stroke residual disabilities,” said Moss Rehab’s Chief Medical Officer Alberto Esquenazi, MD, who was one of the investigators in the multi-center trial. “By training the patient walking pattern in a more correct way, the expectation is that the brain will re-learn and better restore the walking function lost after a stroke.”

WT | Wearable Technologies Conference in San Francisco on July 9-10

The most innovative wearables event will be back on July 9-10 in beautiful San Francisco at SEMICON West to celebrate the 34th edition of the WT | Wearable Technologies Conference Series. Topics include data analytics in professional sports, prevention, treatment and rehabilitation with wearables, the future of digital health, medication and adherence, smart patches, workflow optimization and workforce safety and much more – featuring international leaders and experts of the wearables industry´s biggest names including Abbott, Autodesk, Datwyler, Kopin, Maxim Integrated, Multek, NFLPA, Omron, SharkDreams, Qualcomm, and many more. Register now to be part of #WTUS1

Taiwanese healthtech startup, iWEECARE, bagged US$1 million in a pre-series A round led by Singapore’s Verge HealthTech Fund. Local venture capital firm Darwin Venture and US-based Translink Capital also participated in the round.

The company said it plans to use the fresh funds to help is global expansion efforts.

Related Wearable Digital Thermometer Detects Fever Quicker than Current SOC method

In addition to the funding, iWEECARE also just received regulatory approval to market its flagship product, Temp Pal, which it claims to be the world’s smallest smart thermometer, in both the EU and Taiwan.

Temp Pal is a comprehensive and convenient wireless body temperature tracking device that provides real-time monitoring combined with smart alerts, reports MobiHealthNews.

The patented stamp-sized soft, flexible patch has a high-performance temperature sensor with a battery life of 2-3 days. It can also be connected via Bluetooth to transmit body data to a secure cloud through its mobile app, delivering real-time charts and smart alerts. The wearable device can also be applied in hospitals and clinics as it offers centralized tracking and analytics from multiple devices.

Related Covestro Unveils Smart Bracelet that Regulates Body Temperature

“It is also crucial to real-time continuous monitor body temperature for infants, patients and couples who plan to be pregnant. Traditional thermometers rely on human behavior and efforts to test periodically, resulting in interruptions of quality of life and ambiguous health care decisions,” said the company’s CEO Glen Tseng. “Our company hope to address the issues with a friendly and comfortable solution.”

WT | Wearable Technologies Conference in San Francisco on July 9-10

The most innovative wearables event will be back on July 9-10 in beautiful San Francisco at SEMICON West to celebrate the 34th edition of the WT | Wearable Technologies Conference Series. Topics include data analytics in professional sports, prevention, treatment and rehabilitation with wearables, the future of digital health, medication and adherence, smart patches, workflow optimization and workforce safety and much more – featuring international leaders and experts of the wearables industry´s biggest names including Abbott, Autodesk, Datwyler, Kopin, Maxim Integrated, Multek, NFLPA, Omron, SharkDreams, Qualcomm, and many more. Register now to be part of #WTUS19

Netanya, Israel-based medical device company Sorrel Medical develops and manufactures pre-filled wearable injectors for the easy and efficient self-administration of large volume and high viscosity medications.

Related How Microneedle Systems Could Provide Safe, Effective and Painless Drug Delivery

One of three privately held companies operating under the Eitan Group, Sorrel leverages core capabilities and expertise in drug delivery technology development, manufacturing and regulatory experience to offer a robust platform solution to the healthcare market. With innovative technology solutions, Sorrel’s devices address the need for partner-oriented and patient-centric drug delivery systems.

“Sorrel is committed to providing simple and easy to use solutions that enhance the self-administration experience while encouraging adherence to treatment therapies. Creating a truly patient-centric experience, our devices are discreet, fully-disposable, and able to meet a variety of specific drug requirements from multiple pharmaceutical partners,” said Andrei Yosef, PhD, CEO for Sorrel Medical.

Sorrel recently won “Best New Technology Solution in Drug Delivery” designation from MedTech Breakthrough, an independent organization, said a press release.

Sorrel’s wearable devices are designed to accommodate drug reservoirs ranging from 1 mL to 20 mL in volume. The devices utilize a variety of smart sensors to guarantee successful self-administration and first-of-its-kind UV LED technology to provide disinfection at point-of-care – addressing a longstanding challenge in pre-filled drug delivery devices. Finally, the devices are able to connect to both Bluetooth and near-field communication (NFC) platforms, allowing patients to share treatment information with caregivers, healthcare providers, and other necessary stakeholders.

Related Tiny Cell-sized Microbots Could Help in Drug Delivery

WT | Wearable Technologies Conference in San Francisco on July 9-10

The most innovative wearables event will be back on July 9-10 in beautiful San Francisco at SEMICON West to celebrate the 34th edition of the WT | Wearable Technologies Conference Series. Topics include data analytics in professional sports, prevention, treatment and rehabilitation with wearables, the future of digital health, medication and adherence, smart patches, workflow optimization and workforce safety and much more – featuring international leaders and experts of the wearables industry´s biggest names including Abbott, Autodesk, Datwyler, Kopin, Maxim Integrated, Multek, NFLPA, Omron, SharkDreams, Qualcomm, and many more. Register now to be part of #WTUS19

Nemaura, a Loughborough, England-based medical technology company received CE approval for its non-invasive, affordable and flexible Continuous Glucose Monitor (CGM) SugarBEAT® for use by diabetics and pre-diabetics. This approval allows Nemaura to sell SugarBeat throughout the European Union.

Related Senseonics Gets FDA Approval for Long-Term Implantable CGM Eversense

“We are very pleased to report CE Mark approval in Europe for SugarBEAT®, which is the world’s first non-invasive, needle-free, continuous glucose monitor (CGM).  Importantly, as a daily disposable adhesive skin-patch that sits on the surface of the skin, SugarBEAT® is painless, and versatile in terms of wear time. Given these benefits, we look forward to aggressively entering both the multi-billion-dollar diabetic (insulin and non-insulin dependent) and pre-diabetic markets, said Dr. Faz Chowdhury, CEO of Nemaura.

“In addition, we plan to target the wearable health tech market for health-conscious consumers, which is experiencing explosive growth. Due to the non-invasive nature of the sensor patch and connection to a rechargeable transmitter, SugarBEAT® will allow users the freedom to decide when, and for how long to wear the patch. Moreover, we have a unique competitive advantage, which we believe will make SugarBEAT® the lowest priced CGM device in the industry.  SugarBEAT® is protected by a solid IP portfolio with over 30 issued and pending patents across multiple patent families.”

Related Cellnovo Launches New Mobile App that Connects Directly to CGM Data via HealthKit

Key features of SugarBeat

• Non-invasive, needle-free, disposable adhesive skin-patch connected to a rechargeable transmitter
• Lowest priced CGM in the industry
• Enables users to spend more time in range (TIR) by providing an ambulatory glucose profile (AGP) chart

Nemaura plans to submit application for U.S. FDA approval in mid-2019, the company said in a news release.

Product launch in United Kingdom and Germany is planned for next quarter.

WT | Wearable Technologies Conference in San Francisco on July 9-10

The most innovative wearables event will be back on July 9-10 in beautiful San Francisco at SEMICON West to celebrate the 34th edition of the WT | Wearable Technologies Conference Series. Topics include data analytics in professional sports, prevention, treatment and rehabilitation with wearables, the future of digital health, medication and adherence, smart patches, workflow optimization and workforce safety and much more – featuring international leaders and experts of the wearables industry´s biggest names including Abbott, Autodesk, Datwyler, Kopin, Maxim Integrated, Multek, NFLPA, Omron, SharkDreams, Qualcomm, and many more. Register now to be part of #WTUS19

Flow, a Malmö, Sweden-based medical device company Flow, announced that it is launching its brain stimulation headset and therapy app to treat depression in the UK.

Related Wearable Devices and Mobile Apps Exploring Users’ States of Mind to Tackle Anxiety and Depression

Mental illness affects nearly one in four adults in the UK, and suicide is the most common cause of death for men aged 20-49 years in England and Wales.

Flow’s technology has similar outcomes as antidepressants, but with fewer side effects, reports EU startups.

Paired with a behavioral therapy app, Flow’s headset delivers low levels of transcranial direct current stimulation (tDCS) aimed at the user’s left frontal lobe. According to the company, people diagnosed with depression often have lower neural activity in this region of the brain, which helps govern certain cognitive skills and emotional expression.

“It works by sending a weak electric current, the equivalent of a 9-volt battery, into the frontal parts of the brain. The result is increased activity in the left part of the frontal lobe and decreased activity in the right part of the brain,” Flow said on its website.

During brain stimulation, the free app provides videos and advice about depression, and techniques for reducing symptoms focused on sleep, nutrition, fitness and meditation. This is informed by expert knowledge in sleep, nutrition, fitness and medication.

The typical course of treatment with the Flow headset lasts for 30 minutes per brain-stimulation session, with 18 sessions over six weeks. Continued treatment will then take place once or twice a week.

Related VivaLNK Offers its Wearable Healthcare Devices to Stanford University for Study on Stress and Teenage Depression

“We want to support the improvement of the current standard of care for people living with depression by increasing treatment choice and empowering patients to self-manage their symptoms at home with effective, non-pharmacological alternatives,” said Daniel Mansson, co-founder and CEO of Flow.

People using Flow’s treatment should not stop their current therapy, the company warns, and it is not recommended for pregnant women or people under 18.

The headset retails for £399 (about $500 U.S.).

WT | Wearable Technologies Conference in San Francisco on July 9-10

The most innovative wearables event will be back on July 9-10 in beautiful San Francisco at SEMICON West to celebrate the 34th edition of the WT | Wearable Technologies Conference Series. Topics include data analytics in professional sports, prevention, treatment and rehabilitation with wearables, the future of digital health, medication and adherence, smart patches, workflow optimization and workforce safety and much more – featuring international leaders and experts of the wearables industry´s biggest names including Abbott, Autodesk, Datwyler, Kopin, Maxim Integrated, Multek, NFLPA, Omron, SharkDreams, Qualcomm, and many more. Register now to be part of #WTUS19

Global shipments of wearable devices reached 49.6 million units during the first quarter of 2019, up 55.2% from the previous year, according to market research firm IDC. Not surprisingly, Apple maintained its industry-leading market share thanks to growth in shipments of Apple Watches, AirPods, and Beats headphones. Huawei, with all the troubles building up over its businesses, posted 282.2% gains. Apple’s Asian rivals Xiaomi, Huawei, and Samsung all saw sharper year-over-year increases than the Cupertino tech giant.

Read more Apple’s New Patents Hint at Watch that Detects Smell to Monitor Glucose

While wrist-worn wearables accounted for the majority of the market with 63.2% share, ear-worn devices experienced the fastest growth (135.1% year over year) and accounted for 34.6% of all wearables shipped, the IDC report said.

“The elimination of headphone jacks and the increased usage of smart assistants both inside and outside the home have been driving factors in the growth of ear-worn wearables,” said Jitesh Ubrani research manager for IDC Mobile Device Trackers. “Looking ahead, this will become an increasingly important category as major platform and device makers use ear-worn devices as an on-ramp to entice consumers into an ecosystem of wearable devices that complement the smartphone but also offer the ability to leave the phone behind when necessary.”

Leading Company Highlights

Apple still leads the wearables market with Apple Watch, AirPods, and select Beats headphones.

Xiaomi ranked second largely due to the popularity of its Mi Band, which accounted for roughly five million shipments.

Read more Children are Becoming Major Driving Force Behind the Wearable Market Growth in China

Samsung, like Apple, also offers multiple product lines including the Gear/Galaxy watches and bands, the Galaxy Buds, and select JBL headphones.

Fitbit rounded out the top 5 and maintained its positive growth trajectory. The recent launch of the Versa Lite as well as the Inspire series has helped the company reach new users as well as encouraged upgrades, although this has come at the expense of a lower ASP.

WT | Wearable Technologies Conference in San Francisco on July 9-10

The most innovative wearables event will be back on July 9-10 in beautiful San Francisco at SEMICON West to celebrate the 34th edition of the WT | Wearable Technologies Conference Series. Topics include data analytics in professional sports, prevention, treatment and rehabilitation with wearables, the future of digital health, medication and adherence, smart patches, workflow optimization and workforce safety and much more – featuring international leaders and experts of the wearables industry´s biggest names including Abbott, Autodesk, Datwyler, Kopin, Maxim Integrated, Multek, NFLPA, Omron, SharkDreams, Qualcomm, and many more. Register now to be part of #WTUS19

Paying for the world’s largest subway system ride is now much easier with contactless payment option. Starting May 31, New Yorkers, and even visitors can pay for their ride by tapping a credit and debit card at the 16 of New York City’s 472 subway stations – along with some of its buses.

Fitbit is now included in the growing list of device makers that will support tap-to-pay in New York City’s mass transit system.

Related Sydney Commuters Can Now Use Credit or Debit Cards to Tap Onto Trains

“We’re excited to work with FitBit and others to help us provide added value and everyday convenience to our customers,” said Al Putre, One Metro New York executive director at the MTA. “We are always looking for ways to enhance the transit experience and help New Yorkers and visitors alike get to their destination faster and make payment more convenient, and now they can do so with any FitBit wearable that supports FitBit pay with a simple tap of the wrist.”

Fitbit Pay-equipped wearables like Fitbit  Charge 3 Special Edition, Versa Special Edition or Fitbit Ionic will let you pay per ride on the Metropolitan Transit Authority’s (MTA) Staten Island buses as well as the 4, 5 and 6 subway lines running between Grand Central and Atlantic Avenue-Barclays Center, reports Tech Crunch.

In addition to bringing Fitbit Pay to one of the largest and busiest public transit systems in the world with the MTA, Fitbit continues to expand its global transit system capabilities to serve commuters and travelers from all over. Fitbit Pay can now be used across seven open and closed loop transit systems, including Chicago Transit Authority (CTA), Singapore Land Transport Authority (LTA), Sydney transport for New South Wales (NSW) train, ferry and light rail services, Taiwan iPASS, TransLink in Vancouver and Transport for London (TfL), with plans to bring Fitbit Pay to more global transit systems in the future.

Related Visa and Planeta Informatica Launch New Technology to Bring Speed and Security of Contactless Payment to Transit Operators Worldwide

“In addition to helping our users get healthier and more active, we’re committed to delivering holistic experiences on our trackers and smartwatches that help keep our 27 million active users engaged,” said James Park, CEO and co-founder of Fitbit. “As we expand the use of Fitbit Pay to work with the MTA and other major transit systems around the globe, we are enabling our on-the-go customers to safely and easily pay for transit with devices that are broadly compatible and have long battery life – all making it easier to go about their day.”

WT | Wearable Technologies Conference in San Francisco on July 9-10

The most innovative wearables event will be back on July 9-10 in beautiful San Francisco at SEMICON West to celebrate the 34th edition of the WT | Wearable Technologies Conference Series. Topics include data analytics in professional sports, prevention, treatment and rehabilitation with wearables, the future of digital health, medication and adherence, smart patches, workflow optimization and workforce safety and much more – featuring international leaders and experts of the wearables industry´s biggest names including Abbott, Autodesk, Datwyler, Kopin, Maxim Integrated, Multek, NFLPA, Omron, SharkDreams, Qualcomm, and many more. Register now to be part of #WTUS19

Semtech, a leading supplier of analog and mixed-signal semiconductors and advanced algorithms, announced that its Design Partner Program had nearly quadrupled from seven design services partners in September of 2018 to 26 partners. The program accelerates Internet of Things (IoT) solutions to market by directly connecting customers with firms specializing in LoRa® devices and wireless radio frequency technology (LoRa Technology).

Related Semtech and Sonova Partner Up to Create Hearing Aid for Better IoT Connectivity

“The Design Partner Program enables customers, system integrators, and developers looking to create an innovative LoRa-based solution to work directly with experienced firms,” said Marc Pegulu, Vice President of IoT for Semtech’s Wireless and Sensing Products Group. “The goal of this project is to simplify deployment and accelerate time-to-market for new solutions. As the program grows, prospective developers now have a larger selection and variety of services available. Given the wider range of choices, customers can find a Design Partner that better suits their development needs. With Design Partner expertise we believe customers can more quickly and successfully develop their applications.”

The Design Partner Program currently includes companies from North and South America, Europe and Asia. Partner companies offer a wide range of products and services, including hardware design and layout, digital and analog design, embedded firmware, application code, security, and Cloud integration, the company said in a press release.

Semtech’s LoRa devices and wireless radio frequency technology is a widely adopted long-range, low-power solution for IoT that gives telecom companies, IoT application makers and system integrators the feature set necessary to deploy low-cost, interoperable IoT networks, gateways, sensors, module products, and IoT services worldwide. IoT networks based on the LoRaWAN® specification have been deployed in 100 countries and Semtech is a founding member of the LoRa Alliance™, the fastest growing IoT Alliance for Low Power Wide Area Network applications.

Related How IoT is Shaping the Smart Cities of Tomorrow

The companies that have been added to the Design Partner Program since its initial rollout are: ALCIOM, allóra Factory, Always Wireless, Bresslergroup, Cargt, Deep Thought Systems, INES, Innovel, Invoxia, Kerlink, Laird Connectivity, Matchbox Mobile, Miromico AG, NextGen RF Design, Onethinx BV, PROESYS Srl, RF Track, Signetik, and STIMIO.

WT | Wearable Technologies Conference in San Francisco on July 9-10

The most innovative wearables event will be back on July 9-10 in beautiful San Francisco at SEMICON West to celebrate the 34th edition of the WT | Wearable Technologies Conference Series. Topics include data analytics in professional sports, prevention, treatment and rehabilitation with wearables, the future of digital health, medication and adherence, smart patches, workflow optimization and workforce safety and much more – featuring international leaders and experts of the wearables industry´s biggest names including Abbott, Autodesk, Datwyler, Kopin, Maxim Integrated, Multek, NFLPA, Omron, SharkDreams, Qualcomm, and many more. Register now to be part of #WTUS19